Navidea Biopharma (NAVB) Announces Changes to Board of Directors Composition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Navidea Biopharma (NAVB) Announces Changes to Board of Directors Composition

Navidea Biopharmaceuticals Announces Changes to Board of Directors Composition

May 5, 2021 8:00 AM EDT

Industry veteran Amit Bhalla appointed to the Board of Directors

DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (Navidea or the Company), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that Michael Rice, the Companys Chair of the Board, and Adam Cutler have retired from their positions on Navideas Board of Directors to focus on other endeavors. Dr. Kathy Rouan has been appointed as Chair of the Board following Mr. Rices retirement.

Additionally, Amit Bhalla has been appointed to... More